“…Phosphoserine modified cements (PMCs), including the non-adhesive cement formulations studied by Reinstorf et al [29,30,31], have been investigated for hard tissue applications because: (a) many of the chemical and physical properties of cured/set PMC mirror those of the mineral phase of bone (i.e., strong compressive strength [31], presence of amorphous and crystalline calcium phosphate, etc. ); (b) phosphoserine exerts a direct stimulatory effect on the proliferation and differentiation of osseous cell types, including osteoblasts [32,33,34,35,36], stem cells [36,37], and endothelial cells [32,33,34,35,36], and can increase the expression of bone morphogenetic protein (BMP-2) and runt-related transcription factor (RUNX2) [32,36]; and (c) can improve the physical properties, (i.e., high compressive strength [31], strong bonding to calcified tissue surfaces [38,39,40], etc. ), and immune-/histo-compatibility, of cements in vivo (i.e., by accelerating resorption and replacement of cement with new bone, and increasing the numbers of recruited macrophages and osteoclasts) [35,41].…”